Pura Vida Investments, LLC Concert Pharmaceuticals, Inc. Call Options Transaction History

Pura Vida Investments, LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2019 Nov 14, 2019	SELL	$5.88 - $12.35 $1.32 Million - $2.78 Million	-224,900 Closed	0 $0
Q2 2019 Feb 12, 2021	BUY	$9.44 - $13.12 $2.1 Million - $2.92 Million	222,651 Added 9900.0%	224,900 $2.7 Million
Q2 2019 Aug 14, 2019	SELL	$9.44 - $13.12 $2.1 Million - $2.92 Million	-222,651 Reduced 99.0%	2,249 $17,000
Q1 2019 Feb 12, 2021	BUY	$12.07 - $17.54 $2.69 Million - $3.91 Million	222,651 Added 9900.0%	224,900 $2.72 Million
Q1 2019 May 14, 2019	BUY	$12.07 - $17.54 $27,145 - $39,447	2,249 New	2,249 $146,000

Ticker CNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,934,600
Description
Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has s...

Get notified when there are updates to the investment portfolio of Pura Vida Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Pura Vida Investments, LLC with notifications on news.